Uses
USE(S) temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, water eyes itching of the nose or throat
Source: US FDA prescribing information
Molecule
Loratadine is a prescription medicine. It is available as tablets for oral use. MedsAcross supplies Loratadine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
From the regulator-approved product information. Each section names its source.
USE(S) temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, water eyes itching of the nose or throat
Source: US FDA prescribing information
DIRECTIONS adults and children 6 years and over 1 tablet daily, not more than 1 tablet in 24 hours children under 6 years of age ask a doctor consumers with liver or kidney disease ask a doctor
Source: US FDA prescribing information
DO NOT USE if you have ever had an allergic reaction to this product or any of its ingredients
Source: US FDA prescribing information
store between 20º to 25ºC (68º to 77ºF)
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
1 presentations of Loratadine, sorted by availability.
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Loratadine 10 mg tabletOralGeneric name | — | US FDA | Available on request |
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
| Register | Status | Source |
|---|---|---|
| US FDA | First approved 12 April 1993 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Conditions linked to Loratadine in public data. This is not a list of approved uses, see the clinical information.
Yes, on request. MedsAcross lists 1 presentations of Loratadine and sources them for licensed hospitals, importers and physicians against valid import documents.
Yes. The US FDA first approved Loratadine on 12 April 1993, according to Drugs@FDA.
No listed presentation of Loratadine is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Loratadine is classified under ATC code R06AX13 (Loratadine).
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.